PTHLH and prostate carcinoma: These blocking mAbs inhibit growth and metastasis of human PTHrP‐positive breast and prostate cancer(42, 43, 44) and are strong inhibitors of TNBC cell growth in vitro, where they potentiate the effect of doxorubicin and taxol.(45)